A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease

A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease

(1) Background: Sepsis still represents a major health care challenge, with mortality rates exceeding 25% in the western world. To further improve outcomes in this patient collective, new cardiovascular biomarkers present a promising opportunity as they target the paramount prognostic processes in s...

Full description

Bibliographic Details
Main Authors: Peter Jirak, Franz Haertel, Moritz Mirna, Richard Rezar, Michael Lichtenauer, Vera Paar, Lukas J. Motloch, Albert Topf, Atilla Yilmaz, Uta C. Hoppe, P. Christian Schulze, Sebastian Nuding, Karl Werdan, Daniel Kretzschmar, Rudin Pistulli, Henning Ebelt
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Applied Sciences
Subjects:
biomarkers
sepsis
STEMI
heart failure
cardiovascular disease
ST2
Online Access:https://www.mdpi.com/2076-3417/12/3/1419

Internet

https://www.mdpi.com/2076-3417/12/3/1419

Similar Items